Longfellow Investment Management’s Edwards Lifesciences EW Stock Holding History

Longfellow Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.44K	Hold	38	–	–	﹤0.01%	203
2026 Q1	$3.04K	Hold	38	–	–	﹤0.01%	202
2025 Q4	$3.24K	Hold	38	–	–	﹤0.01%	201
2025 Q3	$2.96K	Hold	38	–	–	﹤0.01%	211
2025 Q2	$2.97K	Hold	38	–	–	﹤0.01%	210
2025 Q1	$2.75K	Hold	38	–	–	﹤0.01%	215
2024 Q4	$2.81K	Hold	38	–	–	﹤0.01%	219
2024 Q3	$2.51K	Hold	38	–	–	﹤0.01%	213
2024 Q2	$3.51K	Hold	38	–	–	﹤0.01%	194
2024 Q1	$3.63K	Hold	38	–	–	﹤0.01%	209
2023 Q4	$2.9K	Hold	38	–	–	﹤0.01%	194
2023 Q3	$2.63K	Hold	38	–	–	﹤0.01%	184
2023 Q2	$3.58K	Hold	38	–	–	﹤0.01%	198
2023 Q1	$3.14K	Hold	38	–	–	﹤0.01%	205
2022 Q4	$2.83K	Buy	38 +13	+52%	+$1K	﹤0.01%	216
2022 Q3	$2K	Hold	25	–	–	﹤0.01%	279
2022 Q2	$3K	Hold	25	–	–	﹤0.01%	281
2022 Q1	$3K	Buy	+25	New	+$2.81K	﹤0.01%	313
2021 Q3	–	Sell	-25	Closed	-$3K	–	435
2021 Q2	$3K	Hold	25	–	–	﹤0.01%	363
2021 Q1	$3K	Buy	+25	New	+$2.11K	﹤0.01%	423

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Longfellow Investment Management's EW Position: Q2 2026 in Review

Longfellow Investment Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 38 shares worth $3.44K. The position accounts for ﹤0.01% of the portfolio, ranked #203.

Longfellow Investment Management first reported a position in EW in Q1 2021 and has held it in 20 quarters since. The position peaked at $3.63K in Q1 2024. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Longfellow Investment Management held 38 shares of Edwards Lifesciences worth $3.44K as of Q2 2026.
Longfellow Investment Management left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up ﹤0.01% of Longfellow Investment Management's portfolio in Q2 2026, its #203 holding.
Longfellow Investment Management first reported a position in Edwards Lifesciences in Q1 2021 and has held it in 20 quarters since.
Longfellow Investment Management's Edwards Lifesciences position peaked at $3.63K in Q1 2024.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Longfellow Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.